U.S. Cath Labs Market Size, Share & Trends Analysis Report By Component (Services, Equipment), By Facility Type (Independent Labs, Hospital-based Labs), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Estimates and Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary sources
                       1.3.4 Primary research
                   1.4 Information or Data Analysis
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                   1.7 List of Secondary Sources
                   1.8 List of Abbreviations
                   1.9 Objectives
                       1.9.1 Objective - 1
                       1.9.2 Objective - 2
                       1.9.3 Objective - 3
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.2 Competitive Landscape
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 Market Dynamics
                       3.3.1 Market driver analysis
                           3.3.1.1 Rising incidence of cardiovascular disease
                           3.3.1.2 Low operational cost
                           3.3.1.3 Technological advancement
                       3.3.2 Market restraint analysis
                           3.3.2.1 Lack of reimbursement for independent lab
                           3.3.2.2 High maintenance cost for multispecialty labs
                   3.4 U.S. Cath Labs Industry Analysis - Porter’s
                       3.4.1 Bargaining power of buyers
                       3.4.2 Bargaining power of suppliers
                       3.4.3 Competitive rivalry
                       3.4.4 Threat of new entrants
                       3.4.5 Threat of substitutes
                   3.5 Regulatory & Reimbursement Scenario
                   3.6 Qualitative Analysis: Impact of COVID-19 on U.S. Cath Labs Market
Chapter 4 U.S. Cath Labs Market: Component Analysis
                   4.1 U.S. Cath Labs Component Market Share Analysis, 2022&2030
                   4.2 U.S. Cath Labs ComponentMarket: Segment Dashboard
                   4.3 Market Size & Forecasts and Trend Analyses, Component Segment, 2017 to 2030
                       4.3.1 Services
                           4.3.1.1 Services Market, 2017 - 2030 (USD Million)
                           4.3.1.2 Therapeutic services
                               4.3.1.2.1 Therapeutic services market, 2017 - 2030 (USD Million)
                               4.3.1.2.2 Angioplasty
                                   4.3.1.2.2.1 Angioplasty market, 2017 - 2030 (USD Million)
                               4.3.1.2.3 Stent Placement
                                   4.3.1.2.3.1 Stent Placement market, 2017 - 2030 (USD Million)
                               4.3.1.2.4 Rotational atherectomy
                                   4.3.1.2.4.1 Rotational atherectomy market, 2017 - 2030 (USD Million)
                               4.3.1.2.5 Thrombectomy
                                   4.3.1.2.5.1 Thrombectomy market, 2017 - 2030 (USD Million)
                               4.3.1.2.6 Cardioversion
                                   4.3.1.2.6.1 Cardioversion market, 2017 - 2030 (USD Million)
                               4.3.1.2.7 Transcatheter Aortic Valve Replacement (TAVR)
                                   4.3.1.2.7.1 Transcatheter Aortic Valve Replacement (TAVR) market, 2017 - 2030 (USD Million)
                               4.3.1.2.8 Others
                                   4.3.1.2.8.1 Others market, 2017 - 2030 (USD Million)
                           4.3.1.3 Diagnostic services
                               4.3.1.3.1 Diagnostic services market, 2017 - 2030 (USD Million)
                               4.3.1.3.2 Angiography
                                   4.3.1.3.2.1 Angiography market, 2017 - 2030 (USD Million)
                               4.3.1.3.3 Coronary intravascular ultrasound
                                   4.3.1.3.3.1 Coronary intravascular ultrasound market, 2017 - 2030 (USD Million)
                               4.3.1.3.4 Cardiac catheterization
                                   4.3.1.3.4.1 Cardiac catheterization market, 2017 - 2030 (USD Million)
                               4.3.1.3.5 ECG/EKG
                                   4.3.1.3.5.1 ECG/EKG market, 2017 - 2030 (USD Million)
                               4.3.1.3.6 Fractional Flow Reserve (FFR)
                                   4.3.1.3.6.1 Fractional Flow Reserve (FFR) market, 2017 - 2030 (USD Million)
                               4.3.1.3.7 Others
                                   4.3.1.3.7.1 Others market, 2017 - 2030 (USD Million)
                       4.3.2 Equipment
                           4.3.2.1 Equipment, 2017 - 2030 (USD Million)
Chapter 5 U.S. Cath Labs Market: FacilityType Analysis
                   5.1 U.S. Cath LabsFacilityType Market Share Analysis, 2022& 2030
                   5.2 U.S. Cath Labs FacilityType Market: Segment Dashboard
                   5.3 Market Size & Forecasts and Trend Analyses, FacilityType Segment, 2017 to 2030
                       5.3.1 Independent Labs
                           5.3.1.1 Independent Labs, 2017 - 2030 (USD Million)
                       5.3.2 Hospital-based Labs
                           5.3.2.1 Hospital-based market, 2017 - 2030 (USD Million)
Chapter 6 Competitive Analysis
                   6.1 Recent Developments & Impact Analysis, by Key Market Participants
                   6.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
                   6.3 Company Market Position Analysis
                   6.4 Company Profiles
                       6.4.1 Koninklijke Philips N.V.
                           6.4.1.1 Company overview
                           6.4.1.2 Financial performance
                           6.4.1.3 Service benchmarking
                           6.4.1.4 Strategic initiatives
                       6.4.2 Shimadzu Corporation
                           6.4.2.1 Company overview
                           6.4.2.2Financial performance
                           6.4.2.3 Service benchmarking
                           6.4.2.4 Strategic initiatives
                       6.4.3 GE Healthcare
                           6.4.4.1Company overview
                           6.4.4.2Financial Performance
                           6.4.4.3 Service benchmarking
                           6.4.4.4 Strategic initiatives
                       6.4.4 Johnson & Johnson
                           6.4.4.1Company overview
                           6.4.4.2Financial Performance
                           6.4.4.3 Service benchmarking
                           6.4.4.4 Strategic initiatives
                       6.4.5 Braun Melsungen AG
                           6.4.5.1 Company overview
                           6.4.5.2 Financial Performance
                           6.4.5.2 Service benchmarking
                           6.4.5.3 Strategic initiatives
                       6.4.6 Siemens Healthineers
                           6.4.6.1 Company overview
                           6.4.6.2 Financial performance
                           6.4.6.3 Service benchmarking
                           6.4.6.4 Strategic initiatives
                       6.4.7 Medtronic
                           6.4.7.1 Company overview
                           6.4.7.2 Financial performance
                           6.4.7.3 Service benchmarking
                           6.4.7.4 Strategic initiatives
                       6.4.8 Cardinal Health, Inc.
                           6.4.8.1 Company overview
                           6.4.8.2 Financial performance
                           6.4.8.3 Service benchmarking
                           6.4.8.4 Strategic initiatives
                       6.4.9 Boston Scientific Corporation
                           6.4.9.1 Company overview
                           6.4.92 Financial performance
                           6.4.9.3 Service benchmarking
                           6.4.9.4 Strategic initiatives
                       6.4.10 Abbott Laboratories
                           6.4.10.1 Company overview
                           6.4.10.2 Financial performance
                           6.4.10.3 Service benchmarking
                           6.4.10.4 Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S.cath labsmarketestimates and forecast, by component, 2017 - 2030 (USD Million)
Table 4 U.S.cath labs market estimates and forecast, by facility type 2017 - 2030 (USD Million)
Table 5 U.S.cath labs services market estimates and forecast, by type 2017 - 2030 (USD Million)
Table 6 U.S.cath labs therapeuticservices market estimates and forecast, by type 2017 - 2030 (USD Million)
Table 7 U.S.cath labs diagnosticservices market estimates and forecast, by type 2017 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. Cath labs market segmentation
Fig. 9 Market outlook, 2022 (USD Million)
Fig. 10 U.S. Cath labs market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 U.S. Cath labs component market share analysis, (USD Million)
Fig. 15 U.S Cath labs component market: Segment dashboard
Fig. 16 Services market, 2017 - 2030 (USD Million)
Fig. 18 Therapeutic services market, 2017 - 2030 (USD Million)
Fig. 19 Angioplasty market, 2017 - 2030 (USD Million)
Fig. 20 Stent placement market, 2017 - 2030 (USD Million)
Fig. 21 Rotational atherectomy market, 2017 - 2030 (USD Million)
Fig. 22 Thrombectomy market, 2017 - 2030 (USD Million)
Fig. 23 Cardioversion market, 2017 - 2030 (USD Million)
Fig. 24 TAVR market, 2017 - 2030 (USD Million)
Fig. 25 Others market, 2017 - 2030 (USD Million)
Fig. 26 Diagnostic services market, 2017 - 2030 (USD Million)
Fig. 27 Angiography market, 2017 - 2030 (USD Million)
Fig. 28 Coronary intravascular ultrasound market, 2017 - 2030 (USD Million)
Fig. 29 Cardiac catheterization atherectomy market, 2017 - 2030 (USD Million)
Fig. 30 ECG/EKG market, 2017 - 2030 (USD Million)
Fig. 31 Fractional flow reserve market, 2017 - 2030 (USD Million)
Fig. 32 Others market, 2017 - 2030 (USD Million)
Fig. 33 Equipment market, 2017 - 2030 (USD Million)
Fig. 34 U.S. Cath labs facility type market share analysis, (USD Million)
Fig. 35 U.S Cath labs facility type market: Segment dashboard
Fig. 36 Independent labs market, 2017 - 2030 (USD Million)
Fig. 37 Hospital-based labs market, 2017 - 2030 (USD Million)
Fig. 38 Impact analysis by key market participants
Fig. 39Competition categorization
Fig. 40 Company market position analysis